David Gaiero - Dec 20, 2021 Form 4 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role
Chief Financial Officer
Signature
/s/ Adam M. Veness, as attorney-in-fact for David Gaiero
Stock symbol
CYT
Transactions as of
Dec 20, 2021
Transactions value $
$6,888
Form type
4
Date filed
2/7/2023, 03:38 PM
Previous filing
Jun 17, 2021
Next filing
Feb 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYT Common Stock Options Exercise $6.89K +4.1K $1.68 4.1K Dec 20, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYT Stock Option (Right to Buy) Options Exercise $0 -4.1K -5.27% $0.00 73.6K Dec 20, 2021 Common Stock 4.1K $1.68 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Due to rounding in connection with the Issuer's reverse stock split during its initial public offering, the exercise price for this option was immaterially incorrect as reported on the Reporting Person's Form 3 filing on June 17, 2021, and has been corrected in this Form 4.
F2 The option vested as to 25% of the underlying shares of common stock on December 7, 2021, the first anniversary of the vesting commencement date, and vests 1/48th of the underlying shares thereafter on each subsequent monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney